INDUSTRIES & MARKETS

The femtech industry

 Table of Contents

01 Worldwide overview 03 Femtech in Europe

Femtech market size worldwide 2021-2030 04 Femtech companies in Europe in 2022 by subsector 24
Leading femtech companies worldwide in 2021, by market capitalization 05 Use and awareness of femtech in the UK 2021, by age 25
Femtech companies worldwide in 2022, by region 06 Use of women's digital health platforms in the UK 2021, by age 26
Femtech companies worldwide in 2022 by subsector 07 Main issues women faced when accessing healthcare in the UK 2022 27
Femtech companies worldwide in 2022, by estimated revenue 08 Main changes women would make to healthcare in the UK 2022 28
Femtech R&D centers worldwide in 2022, by region 09 Issues women are uncomfortable talking with healthcare professionals about in England 29
Leading countries for investment in the femtech industry 2022 10 Experiences of healthcare professionals not listening to women in England 2021 by age 30
Largest investment deals in the femtech industry Q2 2022 11 Healthcare professionals not listening to women in England 2021 by nature of issue 31
Number of femtech companies worldwide in 2021, by subsection 12
Number of exits involving femtech companies worldwide 1990-2021, by subsection 13 04 Femtech in Asia
Assessment of top femtech apps for data sharing policies worldwide in 2021 14 Femtech adoption rate by country SEA 2022 33
Assessment of top femtech apps for data gathering policies worldwide in 2021 15 Awareness level of the word "FemTech" among women Japan 2023 34
Most used type of FemTech services among women Japan 2022 35
02 Femtech in North America Purposes of femtech use Thailand 2022 36
U.S. Femtech companies 2011-2020, by sector 17 Femtech products and services used Singapore 2022 37
Femtech companies in North America in 2022 by subsector 18 Femtech products and services used Malaysia 2022 38
Value of venture funding in femtech digital health companies in the U.S. 2012-2021 19 Purpose of femtech use Vietnam 2022 39
Share of venture funding in femtech digital health in the U.S. 2012-2021 20
Use of women's digital health platforms in the U.S. 2021, by age 21 05 Future prospects
Use and awareness of femtech in the U.S. 2021, by age 22 Market value of women's health worldwide forecast for 2027, by subsection 41

1
 Table of Contents

Opinion on future opportunities in the femtech industry as of 2021 42

Opinion on challenges to future development in the femtech industry as of 2021 43
Projected sales growth in the femtech industry as of 2021, by subsector 44
Opinion on increasing size of staff in the femtech industry as of 2021 45

2
CHAPTER 01

Worldwide overview
 Femtech market size worldwide from 2021 to 2030 (in billion U.S. dollars)
Femtech market size worldwide 2021-2030

120

103
100 95.26
88.1
Market size in billion U.S. dollars

81.49
80 75.36
69.7
64.47
59.62
60 55.14
51

40

20

0
2021 2022* 2023* 2024* 2025* 2026* 2027* 2028* 2029* 2030*

4 Description: In 2021, the femtech market was worth around 51 billion U.S. dollars worldwide. It was forecast that the global femtech market would be worth 103 billion U.S. dollars by 2030, increasing at a compound annual growth rate of 8.1 percent from 2022 to
2030. Read more
Note(s): Worldwide; 2022; * Forecast. Read more
Source(s): Precedence Research
 Leading femtech companies worldwide in 2021, by market capitalization
(in billion U.S. dollars)
Leading femtech companies worldwide in 2021, by market capitalization

Market cap in billion U.S. dollars

0 5 10 15 20 25 30 35 40 45 50

Pulsenmore 47.3

Natera 8.8

Progyny 4.6

Invitae 3.8

Myriad Genetics 2.1

Myovant Sciences 1.5

Mithra Pharmaceuticals 0.9

Owlet 0.45

Progenity 0.45

Sera Prognostics 0.31

Aspira Women's Health 0.22

Therapeutics 0.19

ObsEva 0.17

Dare Bioscience 0.16

Minerva Surgical 0.16

5 Description: In 2021, Pulsenmore, a company which specializes in portable ultrasound devices for use at home, was the top performing publicly traded company in the femtech sector with a market capitalization valued at over 47 billion U.S. dollars. Ranking second on
the list was Natera with a market capitalization valued at 8.8 billion U.S. dollars. Read more
Note(s): Worldwide; 2021
Source(s): FemTech Analytics
 Distribution of femtech companies worldwide in 2022, by region
Femtech companies worldwide in 2022, by region

60%

51%
50%

40%
Share of companies

30% 27%

20%

9%
10%
6%
3% 2% 2%
0%
North America Europe Asia MENA Australia & Oceania LATAM Africa

6 Description: In 2022, North America accounted for approximately 51 percent of femtech companies worldwide, by far the region with the highest share of femtech companies. Furthermore, in this year 27 percent of femtech companies were based in Europe. Femtech
refers to products, services and software based on new technologies which focuses on women's health. Read more
Note(s): Worldwide; Q2 2022
Source(s): FemTech Analytics
 Distribution of femtech companies worldwide in 2022, by subsector
Femtech companies worldwide in 2022 by subsector

Share of companies
0% 5% 10% 15% 20% 25%

Pregnancy and nursing 20%

Reproductive health & contraception 17%

Menstrual health 14%

General healthcare 13%

Pelvic & uterine healthcare 9%

Sexual health 9%

Women's wellness 7%

Menopause care 6%

Longevity 2%

Mental health 2%

7 Description: In 2022, pregnancy and nursing was the largest single subsector in the femtech industry, accounting for a fifth of all femtech companies worldwide. Furthermore, reproductive health and contraception accounted for 17 percent of femtech companies
globally. Femtech refers to products, services and software based on new technologies which focuses on women's health. Read more
Note(s): Worldwide; Q2 2022
Source(s): FemTech Analytics
 Distribution of femtech companies worldwide in 2022, by estimated
revenue
Femtech companies worldwide in 2022, by estimated revenue

Share of companies
0% 5% 10% 15% 20% 25% 30% 35% 40% 45% 50%

Less than $1M 39%

$1M to $10M 45%

$10M to $50M 11%

$50M to $100M 1%

$100M to $500M 2%

Over $500M 1%

8 Description: In 2022, around one percent of femtech companies globally were estimated to have an annual revenue of more than 500 million U.S. dollars. However, the majority of femtech companies, 84 percent, had annual revenues of less than ten million U.S.
dollars. Read more
Note(s): Worldwide; 2022
Source(s): FemTech Analytics
 Distribution of femtech R&D centers worldwide in 2022, by region
Femtech R&D centers worldwide in 2022, by region

50%
47%

45%

40%

35% 33%
Share of R&D labs

30%

25%

20%

15% 13%

10%
7%

5%

0%
North America Europe MENA APAC

9 Description: In 2021, North America accounted for almost half of all the femtech research and development centers worldwide. Europe had the second largest share of femtech R&D centers at 33 percent. Femtech refers to products, services and software based on
new technologies which focuses on women's health. Read more
Note(s): Worldwide; 2022
Source(s): FemTech Analytics
 Countries to have received the highest amount of investment in the
femtech industry as of 2022 (in million U.S. dollars)
Leading countries for investment in the femtech industry 2022

12,000
11,245

10,000
Investment in million U.S. dollars

8,000

6,000

4,000

2,000 1,376.1
845.3 695.9
401 364.1 207.7 171.3 83.1
0
United States Israel United Kingdom France Switzerland China India Canada Ireland

10 Description: As of Q2 2022, the majority of investment in the femtech industry worldwide had been focused in the United States. At over 11.2 billion U.S. dollars of investment in the U.S., this level dwarfed even the other leading countries on the list. In Israel, there had
been over 1.3 billion U.S. dollars invested into femtech ventures as of the end of the first-half of 2022. Read more
Note(s): Worldwide; August 2022
Source(s): FemTech Analytics
 Largest five investment deals in the femtech industry in Q2 2022 (in million
U.S. dollars)
Largest investment deals in the femtech industry Q2 2022

350
329

300
Investment in million U.S. dollars

250

200

150
125

100

58
50 45
50

0
Sanofi (Post-IPO equity) BillionToOne (Series C round) Equip (Series B round) Pulsenmore (Post-IPO equity) Mirvie (Series B round)

11 Description: In the first half of 2022, the largest investment deal in the femtech industry involved the company Sanofi. The firm, which has a large focus on pharmaceuticals, was involved in an investment deal worth over 329 million U.S. dollars. Read more
Note(s): Worldwide; August 2022
Source(s): FemTech Analytics
 Number of companies specializing in femtech worldwide in 2021, by
subsection of female's health
Number of femtech companies worldwide in 2021, by subsection

Number of companies
0 20 40 60 80 100 120

Menstruation 100

Maternal health 98

Fertility 81

Sexual wellness 57

Reproductive health 39

Breastfeeding 38

Menopause 35

General health 34

Breast health 26

Urinary health 21

Pelvic floor health 21

Contraception 20

Vaginal health 19

Mental health 17

Uterine health 13

12 Description: As of 2021, 100 companies specializing in femtech worldwide were addressing menstruation. Furthermore, 98 companies focused on maternal health and 81 enterprises addressed the subsection of fertility. Read more
Note(s): Worldwide; July 2021
Source(s): Femtech Focus
 Number of exits for companies specializing in femtech worldwide between
1990 and 2021, by subsection of female's health
Number of exits involving femtech companies worldwide 1990-2021, by subsection

Number of companies
0 5 10 15 20 25 30

Maternal health 24

Breast health 16

Menstruation 14

Uterine health 10

Contraception 10

Fertility 10

Reproductive health 6

Sexual wellness 6

Vaginal health 6

Urinary health 5

Menopause 4

General health 2

Pelvic floor health 2

Breastfeeding 1

Hormonal health 1

13 Description: As of 2021, 24 femtech companies focused on maternal health had gone through exits since 1990, the highest amount among the subsections of the femtech industry. Furthermore, 16 companies specializing in breast health had exits between 1990 and
2021. Read more
Note(s): Worldwide; 1990 to 2021
Source(s): Femtech Focus
 Assessment of the data sharing policies of the most popular femtech apps
available on the Google and Apple app stores as of 2021
Assessment of top femtech apps for data sharing policies worldwide in 2021

Share of apps

Not Applicable No Yes

0% 20% 40% 60% 80% 100% 120%

Does the app allow behavior tracking?

100%
13%
Are personal data shared if required by law? 4%
87%
13%
Does the app share users` data with a third party?
87%
9%
Does the app share personal data for research purposes with a third party? 17%
78%
13%
Can the user opt out or withdraw by deleting the app? 13%
74%
17%
Does the app share data with third parties for tracking and analysis? 17%
65%
9%
Does the app allow location tracking? 30%
61%
9%
Can the user delete past data by request? 30%
61%
9%
Can the user change the sharing settings? 39%
52%

14 Description: As of 2021, it was found that 87 percent of the most popular femtech apps available on the Google and Apple stores shared the app users' data with third parties. Furthermore, just over half of the apps assessed allowed the user to change the sharing
settings in the app. Read more
Note(s): Worldwide; January 2021; 23 respondents; Women’s mHealth apps
Source(s): JMIR
 Assessment of the data gathering policies of the most popular femtech
apps available on the Google and Apple app stores as of 2021
Assessment of top femtech apps for data gathering policies worldwide in 2021

Yes No
100%
9% 9%
90%
80% 35% 39%
52%
70%
Share of apps

60%
50% 100%
91% 91%
40%
30% 65% 61%
48%
20%
10%
0%
Does required sensitive Is there an age restriction Does required sensitive Are data collected when a Is an account required to Are data collected when
data include health- for data collection and data include personal user registers through a use the app (ie, does the the app is used?
related personal account creation for data that directly web-based account? app require a login and
information? adult services? identifies the person (eg, password)?
first name, surname,
email, date of birth, and
mobile phone number)?

15 Description: According to an assessment of the most popular femtech apps available in 2021, over 90 percent of the apps required sensitive data that directly identifies the person. Furthermore, around 50 percent of the apps evaluated collected data when the app
was in use. Read more
Note(s): Worldwide; January 2021; 23 respondents; Women’s mHealth apps
Source(s): JMIR
CHAPTER 02

Femtech in North America

 Number of femtech companies in the U.S. from 2011 to 2020, by sector*
U.S. Femtech companies 2011-2020, by sector

Number of companies
0 5 10 15 20 25 30

Fertility 24

Sexual & gynecological Health 20

Pregnancy/motherhood 17

Chronic disease 12

Lifestyle/wellness 10

17 Description: As of June 30, 2020, there were a total of 24 U.S. femtech companies specializing in the fertility sector, compared to 12 femtech companies with focus on chronic diseases. This statistic shows the number of femtech companies in the U.S. in the period from
2011 to first half-year 2020, by sector. Read more
Note(s): United States; 2011 to HY1 2020; * Until June 30, 2020. Only includes U.S. deals greater than 2 million U.S. dollars. Each Femtech company can address multiple segments. Since each company may fall into several segments, the total [...] Read more
Source(s): Rock Health
 Distribution of femtech companies in North America in 2022, by subsector
Femtech companies in North America in 2022 by subsector

Share of companies
0% 5% 10% 15% 20% 25%

Pregnancy and nursing 20%

Reproductive health & contraception 17%

General healthcare 14%

Menstrual health 13%

Pelvic & uterine healthcare 9%

Sexual health 9%

Women's wellness 7%

Menopause care 6%

Mental health 2%

Longevity 2%

18 Description: In 2022, pregnancy and nursing was the largest single subsector in the North American femtech industry, accounting for a fifth of all femtech companies in this region. Furthermore, reproductive health and contraception accounted for 17 percent of
femtech companies in North America. Read more
Note(s): North America; Q2 2022
Source(s): FemTech Analytics
 Annual value of venture funding in femtech digital health companies in the
United States from 2012 to 2021 (in million U.S. dollars)
Value of venture funding in femtech digital health companies in the U.S. 2012-2021

1,400
1,300

1,200

1,000
Value in million U.S. dollars

864
774
800

600
493

400

200 124
72 61
38 30 32
0
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021*

19 Description: In the eight months up to the end of August 2021, the value of venture funding towards femtech digital health companies in the United States amounted to approximately 1.3 billion U.S. dollars, the highest funding amount in the provided time interval and
almost double the amount of funding from the previous year. Read more
Note(s): United States; 2012 to 2021; * January to August 2021. Femtech can also be and is referred to in the source as 'women+ health.' To encompass the health needs of cisgender women and those who have the health needs relate to those of [...] Read more
Source(s): Rock Health
 Venture funding in femtech digital health companies as a share of overall digital
health funding in the United States from 2012 to 2021 (in million U.S. dollars)
Share of venture funding in femtech digital health in the U.S. 2012-2021

12%
11%
Femtech funding as a share of digital health

10%

8%
7%

6%
funding

6%
5%

4%

2% 2% 2%
2%
1% 1% 1%

0%
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021*

20 Description: In the eight months up to the end of August 2021, the venture funding towards femtech digital health companies in the United States amounted to seven percent of the total digital health funding. This was in increase in the share from the preceding year,
although in 2019 femtech venture funding accounted for eleven percent of overall funding in the digital health sector. Read more
Note(s): United States; 2012 to 2021; * January to August 2021. Femtech can also be and is referred to in the source as 'women+ health.' To encompass the health needs of cisgender women and those who have the health needs relate to those of [...] Read more
Source(s): Rock Health
 Share of women who use a women's digital health platform monthly in the
United States as of 2021, by age
Use of women's digital health platforms in the U.S. 2021, by age

60%
54% 55%

50%

40%
Share of respondents

31%
30%
25%

20%

10% 7%

0%
18-24 25-34 35-44 45-54 55-64

21 Description: According to a survey carried out in the United States in 2021, 55 percent of women aged between 25 and 34 years of age reported to use a women's digital health platform (WDHP) at least once a month. Due to the focus of WDHP on issues such as
period tracking and conception, the use of these are higher among younger women. Only seven percent of women aged between 55 and 64 years of age reported to use WDHP monthly. Read more
Note(s): United States; 2021; 210 respondents; Women
Source(s): Thrive
 Distribution of the use and awareness of femtech among women in the
United States as of 2021, by age
Use and awareness of femtech in the U.S. 2021, by age

Would use Unsure Would not use Do use No longer use Don't know what femtech is
100%

90%

80%

70%
Share of respondents

60%

50%

40%

30%

20%

10%

0%
18-24 25-34 35-44 45-54 55-64

22 Description: According to a survey carried out in the United States in 2021, a significant proportion of women of all ages admitted to not knowing what femtech was. Four percent of women aged between 25 and 34 years of age reported to use femtech, and a further
18 percent said they would use it, 40 percent of women in this age group didn't know about femtech. Read more
Note(s): United States; 2021; 210 respondents; Women
Source(s): Thrive
CHAPTER 03

Femtech in Europe
 Distribution of femtech companies in Europe in 2022, by subsector
Femtech companies in Europe in 2022 by subsector

Share of companies
0% 2% 4% 6% 8% 10% 12% 14% 16% 18% 20%

Reproductive health & contraception 19%

Pregnancy and nursing 14%

Menstrual health 14%

General healthcare 12%

Menopause care 10%

Pelvic & uterine healthcare 9%

Sexual health 9%

Women's wellness 8%

Mental health 2%

Longevity 2%

24 Description: In 2022, reproductive health and contraception was the largest single subsector in the European femtech industry, accounting for almost a fifth of all femtech companies in this region. Furthermore, pregnancy and nursing as well as menstrual health each
accounted for 14 percent of femtech companies operating in Europe. Read more
Note(s): Europe; Q2 2022
Source(s): FemTech Analytics
 Distribution of the use and awareness of femtech among women in the
United Kingdom (UK) as of 2021, by age
Use and awareness of femtech in the UK 2021, by age

Would use Unsure Would not use Do use No longer use Don't know what femtech is
100%

90%

80%

70%
Share of respondents

60%

50%

40%

30%

20%

10%

0%
18-24 25-34 35-44 45-54 55-64

25 Description: According to a survey carried out in the United Kingdom (UK) in 2021, a large proportion of women of all ages were not sure what femtech was. While, around five percent of women aged between 45 and 54 years of age reported to use femtech, around
half in this age group said they didn't know what femtech was. Read more
Note(s): United Kingdom; 2021; 322 respondents; Women
Source(s): Thrive
 Share of women who use a women's digital health platform monthly in the
United Kingdom (UK) as of 2021, by age
Use of women's digital health platforms in the UK 2021, by age

60%
56%

49%
50%

40%
40%
Share of respondents

32%
30%

20%
15%

10%

0%
18-24 25-34 35-44 45-54 55-64

26 Description: According to a survey carried out in the United Kingdom (UK) in 2021, 56 percent of women aged between 18 and 24 years of age reported to use a women's digital health platform (WDHP) at least once a month. The use of WDHPs being higher among
younger women may be due to the focus of many apps and platforms on conception and the tracking of periods. Only 15 percent of women aged between 55 and 64 years of age reported to use WDHP monthly. Read more
Note(s): United Kingdom; 2021; 322 respondents; Women
Source(s): Thrive
 Main issues experienced by women when accessing healthcare in the
United Kingdom as of 2022
Main issues women faced when accessing healthcare in the UK 2022

50%
Share of women who have experienced problem

44%
45%
39%
40%
34%
35%

30%
26% 25%
25%

20%

15%

10%

5%

0%
Not taken seriously by A lack of understanding of Lack of understanding of Poor communication from Lack of access to
healthcare professional women's lives and experiences female bodies healthcare professional appointments and specialist
services

27 Description: According to a survey of women carried out in the United Kingdom in 2022, 44 percent of respondents had experienced not being taken seriously by a healthcare provider. Furthermore, around 40 percent of women felt that when accessing healthcare,
there was a lack of understanding of women's lives and experiences, while over a third reported a lack of understanding of women's bodies was an issue for them when accessing healthcare. Read more
Note(s): United Kingdom; 2022; 1,013 respondents; 18-65 years; Women
Source(s): Thrive
 Top changes women would like to make to healthcare services in the
United Kingdom as of 2022
Main changes women would make to healthcare in the UK 2022

45%

39%
40%
Share of women who would make change

35%
35%
32%

30%

25%

20%

15%

10%

5%

0%
More specialist services for women Easier access to appointments and services Treatment and care that is adapted to women's
needs

28 Description: According to a survey of women carried out in the United Kingdom in 2022, 39 percent of respondents would like to create more specialist healthcare services for women. Furthermore, just under a third of women would introduce treatment and care
adapted to women's needs if they were able to change something about the healthcare system in the UK. Read more
Note(s): United Kingdom; 2022; 1,013 respondents; 18-65 years; Women
Source(s): Thrive
 Share of women who felt uncomfortable talking about the following health
issues with a healthcare professional in England in 2021
Issues women are uncomfortable talking with healthcare professionals about in England

Share of women uncomfortable discussing health issue

0% 5% 10% 15% 20% 25% 30% 35% 40%

Mental health conditions 36%

Gynecological conditions (e.g. endometriosis, fibroids) 21%

Menstrual wellbeing (e.g. period pain, heavy menstrual bleeding) 20%

Gynecological cancers (womb, ovarian, vulval, and vaginal) 20%

Menopause 19%

Contraception and pregnancy (e.g. fertilty, pregnancy, post-natal support) 18%

Disability, autism, and neurodiversity 16%

General physical health concerns (e.g. diabetes, heart disease) 11%

29 Description: In 2021, over a third of women surveyed in England said they felt uncomfortable talking about mental health conditions with a healthcare professional. Furthermore, gynecological conditions (such as endometriosis) and cancers were uncomfortable
health topics for around a fifth of women to discuss with a healthcare professional. Read more
Note(s): United Kingdom (England); March 8, 2021 to June 13, 2021; 110,123 respondents; Women
Source(s): GOV.UK
 Share of women who felt there were instances where a health or care
professional did not listen to them in England in 2021, by age
Experiences of healthcare professionals not listening to women in England 2021 by age

Share of women who felt they were not listened to

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

16-17 years old 65%

18-19 years old 77%

20-24 years old 86%

25-29 years old 86%

30-39 years old 86%

40-49 years old 84%

50-59 years old 83%

60-69 years old 79%

70-79 years old 76%

30 Description: According to a survey carried out in England in 2021, 86 percent of women aged between 20 and 39 years of age had experienced an instance where they were not listened to by a health or care professional. Across women of all age groups, the majority
had felt there were times that a health or care professional had not listened to them. Read more
Note(s): United Kingdom (England); March 8, 2021 to June 13, 2021; 110,123 respondents; 16-79 years; Women
Source(s): GOV.UK
 Share of women who felt there were instances where a health or care
professional did not listen to them in England in 2021, by nature of discussion
Healthcare professionals not listening to women in England 2021 by nature of issue

Share of women who felt they were not listened to

0% 10% 20% 30% 40% 50% 60% 70% 80%

Discussing symptoms 72%

Seeking referral to a specialist 56%

Discussing treatment options 54%

Asking for more information about an issue or condition 50%

Discussing diagnosis of a condition or disability 41%

Follow-up care 40%

Raising concerns or a complaint 25%

Being asked for consent to a procedure or course of action 10%

Seeking informed consent 8%

Other 1%

31 Description: According to a survey carried out in England in 2021, 72 percent of women who experienced not being listened to by a health or care professional reported it happened when they were discussing symptoms. Furthermore, 56 percent of women felt they
were not listened to when they were seeking referral to a specialist. Read more
Note(s): United Kingdom (England); March 8, 2021 to June 13, 2021; 110,123 respondents; 16-79 years; Women who answered yes to instances of not being listened to by healthcare professional
Source(s): GOV.UK
CHAPTER 04

Femtech in Asia
 Share of women using femtech products or services in Southeast Asia as
of February 2022, by selected country
Femtech adoption rate by country SEA 2022

Share of respondents

No Yes

0% 10% 20% 30% 40% 50% 60% 70% 80% 90%

77%
Singapore
23%

60%
Malaysia
40%

65%
Indonesia
35%

56%
Philippines
44%

59%
Thailand
41%

48%
Vietnam
52%

33 Description: In a survey conducted among Southeast Asian women in February 2022, 52 percent of Vietnamese respondents stated that they used femtech products or services. In comparison, the femtech adoption rate among respondents from Singapore was 23
percent. Femtech includes apps centered around female health advice as well as subscription services for female health products. Read more
Note(s): Asia; February 2022; 3,000 respondents; among female respondents
Source(s): Milieu Insight
 Awareness level of the term "FemTech" among women in Japan as of
March 2023
Awareness level of the word "FemTech" among women Japan 2023

90%

78.3%
80%

70%
Share of respondents

60%

50%

40%

30%

20%
13.1%
10% 5.5%
3.1%
0%
I have used the services and products I know the term and I know the I know the term but I did not know the I do not now the term or meaning
before meaning meaning

34 Description: According to a survey conducted in Japan in 2023, about 78 percent of female respondents in Japan did not know the term "FemTech", which stands for female technology. Only around 5.5 percent of the surveyed women were aware of the meaning of the
word. Read more
Note(s): Japan; March 27 to 28, 2023; 954 respondents; 16-59 years; female respondents
Source(s): Nippon Information Incorporated
 Most commonly used type of services and products of female technology
(FemTech) among women in Japan as of January 2022
Most used type of FemTech services among women Japan 2022

Share of respondents
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

Menstruation/menstrual cycle estimates (period tracker apps, etc.) 86.6%

Menstrual products (menstrual cups, sanitary shorts, etc.) 59.4%

Sexual health (sex toys for women, etc.) 21.4%

35 Description: According to a survey conducted from December 2021 to January 2022, about 87 percent of women who knew the term "FemTech" used services that estimate the start of menstruation or menstrual cycle. Around 60 percent of those women bought
menstrual products such as sanitary shorts before. Read more
Note(s): December 24, 2021 to January 4, 2022; 448 respondents; 10 years and older; multiple answers possible; only leading three items are listed
Source(s): MTI; PR Times
 Purposes of femtech usage in Thailand in February 2022
Purposes of femtech use Thailand 2022

Share of respondents
0% 10% 20% 30% 40% 50% 60% 70% 80%

Period health 73%

General health/wellness 43%

Sexual health/wellness 25%

Menopause 25%

Pregnancy and postpartum 15%

Fertility and infertility 15%

Others 5%

36 Description: In February 2022, a survey conducted on female health and wellness challenges revealed that 73 percent of female respondents in Thailand used femtech products or services for their period health. Other purposes of femtech usage among Thai female
respondents were for their general and sexual health. Read more
Note(s): Thailand; February 2022; 207 respondents; among 3,000 female respondents in Southeast Asia
Source(s): Milieu Insight
 Types of femtech products and services used in Singapore as of February
2022
Femtech products and services used Singapore 2022

Share of respondents
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

Apps (eg. trackers for period and ovulation, support for menopause diagnosis) 86%

Non-subscription delivery for products related to sexual health or wellness (eg.

14%
one- off purchase of emergency contraception, sex toys)

Telemedicine/teleconsultation (i.e online consultations with a professional) 13%

Wearables/devices (eg. detect menopause symptoms, period cramp relief device) 10%

Product subscriptions (eg. monthly birth control pills subscription) 9%

37 Description: A survey conducted by Milieu Insight on female health and wellness in Singapore in January 2022 found that 86 percent of the respondents using femtech were using apps to track their period or ovulation. This was followed by 14 percent of respondents
who were using non-subscription delivery products related to sexual health or wellness. Read more
Note(s): Singapore; February 2022; 117 respondents; among women
Source(s): Milieu Insight
 Types of femtech products and services used in Malaysia as of February
2022
Femtech products and services used Malaysia 2022

Share of respondents
0% 10% 20% 30% 40% 50% 60% 70% 80%

Apps (eg. trackers for period and ovulation, support for menopause diagnosis) 67%

Telemedicine/teleconsultation (i.e online consultations with a professional) 23%

Wearables/devices (eg. detect menopause symptoms, period cramp relief device) 27%

Non-subscription delivery for products related to sexual health or wellness (eg.

23%
one- off purchase of emergency contraception, sex toys)

Product subscriptions (eg. monthly birth control pills subscription) 20%

Others 12%

38 Description: A survey conducted by Milieu Insight on female health and wellness in Malaysia in January 2022 found that 67 percent of the respondents who were using femtech were using apps to track their period or ovulation. The second most common type of
femtech used among respondents were wearables and devices to track female health issues. Read more
Note(s): Malaysia; February 2022; 199 respondents; among women
Source(s): Milieu Insight
 Purposes of femtech usage in Vietnam in February 2022
Purpose of femtech use Vietnam 2022

Share of respondents
0 10 20 30 40 50 60

Period health 56

General health/wellness 46

Sexual health/wellness 31

Pregnancy and postpartum 27

Menopause 26

Fertility and infertility 25

Others 7

39 Description: According to a survey conducted in February 2022 in Vietnam about the purpose of using femtech the highest percent of the female respondents, amounting to 56 percent, used femtech for their period health. Furthermore, 46 percent of female
respondents answered that they used femtech for general health and wellness. Read more
Note(s): Vietnam; February 2022; 259 respondents; among 1,174 female respondents in Southeast Asia
Source(s): Milieu Insight
CHAPTER 05

Future prospects
 Forecast value of the worldwide women's health market by 2027, by
subsection (in billion U.S. dollars)
Market value of women's health worldwide forecast for 2027, by subsection

Forecast market size in billion U.S. dollars

0 50 100 150 200 250

Chronic conditions 218

Reproductive health 171

Breast health 99

Uterine health 75

Cardiovascular 72

Fertility 72

Menstruation 66

Eye health 58

Menopause 53

Sexual wellness 49

Contraception 43

Mental health 41

Maternal health 26

Sleep health 26

Bone health 22

41 Description: By 2027, it was forecast that the subsection focused on women's chronic conditions would be worth 218 billion U.S. dollars globally, the highest value of all the subsections. Furthermore, the women's reproductive health market was forecast to reach a
size of 171 billion U.S. dollars by 2027. Read more
Note(s): Worldwide; 2021
Source(s): Femtech Focus
 Leading opportunities in the femtech industry which will be the focus
according to industry leaders worldwide as of 2021
Opinion on future opportunities in the femtech industry as of 2021

90%

78%
80%

70%
Share of repsondents

60%
51% 50%
50% 45%
43%
40%
40%

30%
20%
20%
9%
10%

0%
Increasing brand Developing a new Attracting skilled Accessing and Improving Expanding to the Transforming the Other
recognition and product talents and experts implementing customer new markets business model
awareness innovations experience

42 Description: According to a survey carried out in December 2021 among founders and CEOs of femtech companies and organizations worldwide, 78 percent of respondents reported that increasing brand recognition and awareness was an opportunity they were
going to focus on in the next 12 months. Furthermore, 51 percent of leaders in the femtech industry said they would be focusing on developing a new product. Read more
Note(s): Worldwide; December 2021; 86*; * Survey was conducted among founders and CEOs of femtech companies, community organizations, and nonprofits organizations across 23 countries. Question was worded in the source as: "Which of [...] Read more
Source(s): FemTech Analytics
 Leading challenges to future development in the femtech industry
according to industry leaders worldwide as of 2021
Opinion on challenges to future development in the femtech industry as of 2021

60%
56%

50%

41%
Share of repsondents

40%

30% 27% 26% 26%

24% 24%
21%
20%

10% 10%
10%

0%
Insufficient Customer Advertising Attracting and Insufficient Domestic Competition Rapid changes Lack of public Economic
investments acquisition bans and retaining talent R&D funding regulation and in market support slowdown
taboo bureaucracy condition

43 Description: According to a survey carried out in December 2021 among founders and CEOs of femtech companies and organizations worldwide, 56 percent of respondents reported that a challenge to future development was insufficient investments. Furthermore,
27 percent cited advertising bans and taboo were a threat to the development of the industry. Read more
Note(s): Worldwide; December 2021; 86*; * Survey was conducted among founders and CEOs of femtech companies, community organizations, and nonprofits organizations across 23 countries. Respondents could choose more than one option. Read more
Source(s): FemTech Analytics
 Projected sales growth for the next 12 months in the femtech industry
according to industry leaders worldwide as of 2021, by subsector
Projected sales growth in the femtech industry as of 2021, by subsector

More than 10% 5-10% 3-5% Up to 3%

100%
13% 8% 8%
90%
8% 8%
80%
15%
70%
Share of repsondents

60%

50%
88%
40% 83%
69%
30%

20%

10%

0%
Fertility and pregnancy Women's medicine Period health

44 Description: According to a survey carried out in 2021 among founders and CEOs of femtech companies and organizations worldwide, 88 percent of respondents focused in the fertility and pregnancy subsector of femech projected they would experience sales growth
of greater than ten percent in the next 12 months. Furthermore, 83 percent of CEOS and founders in women's medicine femtech forecast they would also have sales growth of over ten percent in the next year. Read more
Note(s): Worldwide; September 2021; 48*; * Survey was conducted among founders and CEOs of femtech companies, community organizations, and nonprofits organizations. Question was worded in the source as: "How do you see your projected [...] Read more
Source(s): FemTech Analytics
 Extent to which staff will increase over the next year in the femtech
industry according to industry leaders worldwide as of 2021
Opinion on increasing size of staff in the femtech industry as of 2021

50%

45% 43%

40%

35%
Share of repsondents

30%
25.6%
25%

20%

14%
15% 12.8%

10%
4.7%
5%

0%
Stay the same 1-25 percent 26-50 percent 51-100 percent More than 100 percent

45 Description: According to a survey carried out in December 2021 among founders and CEOs of femtech companies and organizations worldwide, 43 percent of respondents believed their staff numbers would increase by up to 25 percent over the next 12 months.
While, 14 percent of femtech leaders thought their staff numbers will more than double in the next year. Read more
Note(s): Worldwide; December 2021; 86*; * Survey was conducted among founders and CEOs of femtech companies, community organizations, and nonprofits organizations across 23 countries. Question was worded in the source as: "How much [...] Read more
Source(s): FemTech Analytics
 Sources

FemTech Analytics
Femtech Focus
GOV.UK
JMIR
Milieu Insight
MTI
Nippon Information Incorporated
PR Times
Precedence Research
Rock Health
Thrive

46